Skip to content

Device Stimulation for Episodic Migraine

Randomized Controlled Trial for Efficacy of Transcranial Direct Current Stimulation (tDCS) in Patients with Episodic Migraine. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/058543
Enrollment
60
Registered
2023-10-11
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G438- Other migraine

Interventions

Intervention1: Transcranial Direct Current Stimulation: three sessions for three consecutive days- duration of stimulation of 20 minutes per session with a 2-mA intensity of cathodal stimulation Contr

Sponsors

Dept of Neurology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: diagnosed of having episodic migraine with more than 4 and less than 15 migrainous headache days per month and less than 15 headache days per month with persistent headaches despite of one month of stable migraine preventive treatment presenting to the OPD/ emergency in Neurology department of CMC Ludhiana.

Exclusion criteria

Exclusion criteria: 1. Other neurological or neuropsychiatric diseases 2. Other chronic painful syndromes 3. Other types of primary or secondary headaches 4. Epilepsy 5. Metallic head implants or cardiac pacemaker 6. Pregnancy or lactation 7. Substance abuse 8. Brain surgery 9. Prior experience with tDCS 10. Known brain metastasis 11. Use of botulinum toxin in head and neck region during the 6 months prior to screening.

Design outcomes

Primary

MeasureTime frame
Change from baseline in number of migrainous headache days over one monthTimepoint: one month

Secondary

MeasureTime frame
1. Change from baseline in number of headache days over one month 2. Change in headache intensity from baseline a. By VAS score b. By HIT- 6 score 3. Proportion of patients showing =50% reduction from baseline in headache days per month 4. Change from baseline in days of use of acute migraine- specific medication per month 5. Adverse effects of tDCS notedTimepoint: one month

Countries

India

Contacts

Public ContactDr Jeyaraj D Pandian

Christian Medical College and Hospital, Ludhiana

vineeth.jaison@cmcludhiana.in9646900341

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026